A Phase 1, Randomized, Open-Label, Exploratory, Parallel, Pharmacokinetic Single Dose Study of IVL3004 Versus Vivitrol® (Naltrexone) Long-Acting Injectable in Healthy Subjects
A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3004